Global Drug–Device Combination Products Market Insights and Forecast to 2028

  • Report ID:215756
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: May-22
  • No. of Pages: 112

Free Sample

Request Customization

Request A Callback

Enquiry before buying

 
                              

                               
Drug–Device Combination Products market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Drug–Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Infusion Pumps
    Orthopedic Combination Products
    Photodynamic Therapy Devices
    Transdermal Patches
    Drug Eluting Stents
    Wound Care Products
    Inhalers
    Other
Segment by Application
    Hospital
    Clinic
    Other
By Company
    Abbott
    Terumo Corporation
    Stryker Corporation
    Mylan
    Medtronic
    Allergan
    Boston Scientific
    Novartis
    BD
    Teleflex Incorporated
By Region
    North America
        the United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
                           

                       
                        

                         
1 Study Coverage
    1.1 Drug–Device Combination Products Product Introduction
    1.2 Market by Type
        1.2.1 Global Drug–Device Combination Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Infusion Pumps
        1.2.3 Orthopedic Combination Products
        1.2.4 Photodynamic Therapy Devices
        1.2.5 Transdermal Patches
        1.2.6 Drug Eluting Stents
        1.2.7 Wound Care Products
        1.2.8 Inhalers
        1.2.9 Other
    1.3 Market by Application
        1.3.1 Global Drug–Device Combination Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Drug–Device Combination Products Sales Estimates and Forecasts 2017-2028
    2.2 Global Drug–Device Combination Products Revenue Estimates and Forecasts 2017-2028
    2.3 Global Drug–Device Combination Products Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Drug–Device Combination Products Sales by Region
        2.4.1 Global Drug–Device Combination Products Sales by Region (2017-2022)
        2.4.2 Global Sales Drug–Device Combination Products by Region (2023-2028)
    2.5 Global Drug–Device Combination Products Revenue by Region
        2.5.1 Global Drug–Device Combination Products Revenue by Region (2017-2022)
        2.5.2 Global Drug–Device Combination Products Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Drug–Device Combination Products Sales by Manufacturers
        3.1.1 Global Top Drug–Device Combination Products Manufacturers by Sales (2017-2022)
        3.1.2 Global Drug–Device Combination Products Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug–Device Combination Products in 2021
    3.2 Global Drug–Device Combination Products Revenue by Manufacturers
        3.2.1 Global Drug–Device Combination Products Revenue by Manufacturers (2017-2022)
        3.2.2 Global Drug–Device Combination Products Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Drug–Device Combination Products Revenue in 2021
    3.3 Global Drug–Device Combination Products Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Drug–Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Drug–Device Combination Products Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Drug–Device Combination Products Sales by Type
        4.1.1 Global Drug–Device Combination Products Historical Sales by Type (2017-2022)
        4.1.2 Global Drug–Device Combination Products Forecasted Sales by Type (2023-2028)
        4.1.3 Global Drug–Device Combination Products Sales Market Share by Type (2017-2028)
    4.2 Global Drug–Device Combination Products Revenue by Type
        4.2.1 Global Drug–Device Combination Products Historical Revenue by Type (2017-2022)
        4.2.2 Global Drug–Device Combination Products Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
    4.3 Global Drug–Device Combination Products Price by Type
        4.3.1 Global Drug–Device Combination Products Price by Type (2017-2022)
        4.3.2 Global Drug–Device Combination Products Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Drug–Device Combination Products Sales by Application
        5.1.1 Global Drug–Device Combination Products Historical Sales by Application (2017-2022)
        5.1.2 Global Drug–Device Combination Products Forecasted Sales by Application (2023-2028)
        5.1.3 Global Drug–Device Combination Products Sales Market Share by Application (2017-2028)
    5.2 Global Drug–Device Combination Products Revenue by Application
        5.2.1 Global Drug–Device Combination Products Historical Revenue by Application (2017-2022)
        5.2.2 Global Drug–Device Combination Products Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
    5.3 Global Drug–Device Combination Products Price by Application
        5.3.1 Global Drug–Device Combination Products Price by Application (2017-2022)
        5.3.2 Global Drug–Device Combination Products Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Drug–Device Combination Products Market Size by Type
        6.1.1 North America Drug–Device Combination Products Sales by Type (2017-2028)
        6.1.2 North America Drug–Device Combination Products Revenue by Type (2017-2028)
    6.2 North America Drug–Device Combination Products Market Size by Application
        6.2.1 North America Drug–Device Combination Products Sales by Application (2017-2028)
        6.2.2 North America Drug–Device Combination Products Revenue by Application (2017-2028)
    6.3 North America Drug–Device Combination Products Market Size by Country
        6.3.1 North America Drug–Device Combination Products Sales by Country (2017-2028)
        6.3.2 North America Drug–Device Combination Products Revenue by Country (2017-2028)
        6.3.3 the United States
        6.3.4 Canada
7 Europe
    7.1 Europe Drug–Device Combination Products Market Size by Type
        7.1.1 Europe Drug–Device Combination Products Sales by Type (2017-2028)
        7.1.2 Europe Drug–Device Combination Products Revenue by Type (2017-2028)
    7.2 Europe Drug–Device Combination Products Market Size by Application
        7.2.1 Europe Drug–Device Combination Products Sales by Application (2017-2028)
        7.2.2 Europe Drug–Device Combination Products Revenue by Application (2017-2028)
    7.3 Europe Drug–Device Combination Products Market Size by Country
        7.3.1 Europe Drug–Device Combination Products Sales by Country (2017-2028)
        7.3.2 Europe Drug–Device Combination Products Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 UK
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Drug–Device Combination Products Market Size by Type
        8.1.1 Asia Pacific Drug–Device Combination Products Sales by Type (2017-2028)
        8.1.2 Asia Pacific Drug–Device Combination Products Revenue by Type (2017-2028)
    8.2 Asia Pacific Drug–Device Combination Products Market Size by Application
        8.2.1 Asia Pacific Drug–Device Combination Products Sales by Application (2017-2028)
        8.2.2 Asia Pacific Drug–Device Combination Products Revenue by Application (2017-2028)
    8.3 Asia Pacific Drug–Device Combination Products Market Size by Region
        8.3.1 Asia Pacific Drug–Device Combination Products Sales by Region (2017-2028)
        8.3.2 Asia Pacific Drug–Device Combination Products Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Drug–Device Combination Products Market Size by Type
        9.1.1 Latin America Drug–Device Combination Products Sales by Type (2017-2028)
        9.1.2 Latin America Drug–Device Combination Products Revenue by Type (2017-2028)
    9.2 Latin America Drug–Device Combination Products Market Size by Application
        9.2.1 Latin America Drug–Device Combination Products Sales by Application (2017-2028)
        9.2.2 Latin America Drug–Device Combination Products Revenue by Application (2017-2028)
    9.3 Latin America Drug–Device Combination Products Market Size by Country
        9.3.1 Latin America Drug–Device Combination Products Sales by Country (2017-2028)
        9.3.2 Latin America Drug–Device Combination Products Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Drug–Device Combination Products Market Size by Type
        10.1.1 Middle East and Africa Drug–Device Combination Products Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Drug–Device Combination Products Revenue by Type (2017-2028)
    10.2 Middle East and Africa Drug–Device Combination Products Market Size by Application
        10.2.1 Middle East and Africa Drug–Device Combination Products Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Drug–Device Combination Products Revenue by Application (2017-2028)
    10.3 Middle East and Africa Drug–Device Combination Products Market Size by Country
        10.3.1 Middle East and Africa Drug–Device Combination Products Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Drug–Device Combination Products Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott
        11.1.1 Abbott Corporation Information
        11.1.2 Abbott Overview
        11.1.3 Abbott Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Recent Developments
    11.2 Terumo Corporation
        11.2.1 Terumo Corporation Corporation Information
        11.2.2 Terumo Corporation Overview
        11.2.3 Terumo Corporation Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Terumo Corporation Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Terumo Corporation Recent Developments
    11.3 Stryker Corporation
        11.3.1 Stryker Corporation Corporation Information
        11.3.2 Stryker Corporation Overview
        11.3.3 Stryker Corporation Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Stryker Corporation Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Stryker Corporation Recent Developments
    11.4 Mylan
        11.4.1 Mylan Corporation Information
        11.4.2 Mylan Overview
        11.4.3 Mylan Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Mylan Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Mylan Recent Developments
    11.5 Medtronic
        11.5.1 Medtronic Corporation Information
        11.5.2 Medtronic Overview
        11.5.3 Medtronic Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Medtronic Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Medtronic Recent Developments
    11.6 Allergan
        11.6.1 Allergan Corporation Information
        11.6.2 Allergan Overview
        11.6.3 Allergan Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Allergan Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Allergan Recent Developments
    11.7 Boston Scientific
        11.7.1 Boston Scientific Corporation Information
        11.7.2 Boston Scientific Overview
        11.7.3 Boston Scientific Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Boston Scientific Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Boston Scientific Recent Developments
    11.8 Novartis
        11.8.1 Novartis Corporation Information
        11.8.2 Novartis Overview
        11.8.3 Novartis Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Novartis Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Novartis Recent Developments
    11.9 BD
        11.9.1 BD Corporation Information
        11.9.2 BD Overview
        11.9.3 BD Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 BD Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 BD Recent Developments
    11.10 Teleflex Incorporated
        11.10.1 Teleflex Incorporated Corporation Information
        11.10.2 Teleflex Incorporated Overview
        11.10.3 Teleflex Incorporated Drug–Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Teleflex Incorporated Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Teleflex Incorporated Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Drug–Device Combination Products Industry Chain Analysis
    12.2 Drug–Device Combination Products Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Drug–Device Combination Products Production Mode & Process
    12.4 Drug–Device Combination Products Sales and Marketing
        12.4.1 Drug–Device Combination Products Sales Channels
        12.4.2 Drug–Device Combination Products Distributors
    12.5 Drug–Device Combination Products Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Drug–Device Combination Products Industry Trends
    13.2 Drug–Device Combination Products Market Drivers
    13.3 Drug–Device Combination Products Market Challenges
    13.4 Drug–Device Combination Products Market Restraints
14 Key Findings in The Global Drug–Device Combination Products Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
Read More 
                

                 
List of Tables
    Table 1. Global Drug–Device Combination Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Infusion Pumps
    Table 3. Major Manufacturers of Orthopedic Combination Products
    Table 4. Major Manufacturers of Photodynamic Therapy Devices
    Table 5. Major Manufacturers of Transdermal Patches
    Table 6. Major Manufacturers of Drug Eluting Stents
    Table 7. Major Manufacturers of Wound Care Products
    Table 8. Major Manufacturers of Inhalers
    Table 9. Major Manufacturers of Other
    Table 10. Global Drug–Device Combination Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Drug–Device Combination Products Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 12. Global Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
    Table 13. Global Drug–Device Combination Products Sales Market Share by Region (2017-2022)
    Table 14. Global Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
    Table 15. Global Drug–Device Combination Products Sales Market Share by Region (2023-2028)
    Table 16. Global Drug–Device Combination Products Revenue by Region (2017-2022) & (US$ Million)
    Table 17. Global Drug–Device Combination Products Revenue Market Share by Region (2017-2022)
    Table 18. Global Drug–Device Combination Products Revenue by Region (2023-2028) & (US$ Million)
    Table 19. Global Drug–Device Combination Products Revenue Market Share by Region (2023-2028)
    Table 20. Global Drug–Device Combination Products Sales by Manufacturers (2017-2022) & (K Units)
    Table 21. Global Drug–Device Combination Products Sales Share by Manufacturers (2017-2022)
    Table 22. Global Drug–Device Combination Products Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 23. Global Drug–Device Combination Products Revenue Share by Manufacturers (2017-2022)
    Table 24. Drug–Device Combination Products Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 25. Global Drug–Device Combination Products Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 26. Global Drug–Device Combination Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug–Device Combination Products as of 2021)
    Table 27. Drug–Device Combination Products Manufacturing Base Distribution and Headquarters
    Table 28. Manufacturers Drug–Device Combination Products Product Offered
    Table 29. Date of Manufacturers Enter into Drug–Device Combination Products Market
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 32. Global Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 33. Global Drug–Device Combination Products Sales Share by Type (2017-2022)
    Table 34. Global Drug–Device Combination Products Sales Share by Type (2023-2028)
    Table 35. Global Drug–Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 36. Global Drug–Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 37. Global Drug–Device Combination Products Revenue Share by Type (2017-2022)
    Table 38. Global Drug–Device Combination Products Revenue Share by Type (2023-2028)
    Table 39. Drug–Device Combination Products Price by Type (2017-2022) & (USD/Unit)
    Table 40. Global Drug–Device Combination Products Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 41. Global Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 42. Global Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 43. Global Drug–Device Combination Products Sales Share by Application (2017-2022)
    Table 44. Global Drug–Device Combination Products Sales Share by Application (2023-2028)
    Table 45. Global Drug–Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 46. Global Drug–Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 47. Global Drug–Device Combination Products Revenue Share by Application (2017-2022)
    Table 48. Global Drug–Device Combination Products Revenue Share by Application (2023-2028)
    Table 49. Drug–Device Combination Products Price by Application (2017-2022) & (USD/Unit)
    Table 50. Global Drug–Device Combination Products Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 51. North America Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 52. North America Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 53. North America Drug–Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 54. North America Drug–Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 55. North America Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 56. North America Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 57. North America Drug–Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 58. North America Drug–Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 59. North America Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 60. North America Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 61. North America Drug–Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 62. North America Drug–Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 63. Europe Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 64. Europe Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 65. Europe Drug–Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 66. Europe Drug–Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 67. Europe Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 68. Europe Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 69. Europe Drug–Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 70. Europe Drug–Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 71. Europe Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 72. Europe Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 73. Europe Drug–Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 74. Europe Drug–Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 76. Asia Pacific Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 77. Asia Pacific Drug–Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Drug–Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 80. Asia Pacific Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 81. Asia Pacific Drug–Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Drug–Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 83. Asia Pacific Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
    Table 84. Asia Pacific Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
    Table 85. Asia Pacific Drug–Device Combination Products Revenue by Region (2017-2022) & (US$ Million)
    Table 86. Asia Pacific Drug–Device Combination Products Revenue by Region (2023-2028) & (US$ Million)
    Table 87. Latin America Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 88. Latin America Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 89. Latin America Drug–Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 90. Latin America Drug–Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 91. Latin America Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 92. Latin America Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 93. Latin America Drug–Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 94. Latin America Drug–Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 95. Latin America Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 96. Latin America Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 97. Latin America Drug–Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 98. Latin America Drug–Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
    Table 100. Middle East and Africa Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
    Table 101. Middle East and Africa Drug–Device Combination Products Revenue by Type (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Drug–Device Combination Products Revenue by Type (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
    Table 104. Middle East and Africa Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
    Table 105. Middle East and Africa Drug–Device Combination Products Revenue by Application (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Drug–Device Combination Products Revenue by Application (2023-2028) & (US$ Million)
    Table 107. Middle East and Africa Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
    Table 108. Middle East and Africa Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
    Table 109. Middle East and Africa Drug–Device Combination Products Revenue by Country (2017-2022) & (US$ Million)
    Table 110. Middle East and Africa Drug–Device Combination Products Revenue by Country (2023-2028) & (US$ Million)
    Table 111. Abbott Corporation Information
    Table 112. Abbott Description and Major Businesses
    Table 113. Abbott Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Abbott Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Abbott Recent Developments
    Table 116. Terumo Corporation Corporation Information
    Table 117. Terumo Corporation Description and Major Businesses
    Table 118. Terumo Corporation Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Terumo Corporation Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Terumo Corporation Recent Developments
    Table 121. Stryker Corporation Corporation Information
    Table 122. Stryker Corporation Description and Major Businesses
    Table 123. Stryker Corporation Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Stryker Corporation Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Stryker Corporation Recent Developments
    Table 126. Mylan Corporation Information
    Table 127. Mylan Description and Major Businesses
    Table 128. Mylan Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Mylan Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Mylan Recent Developments
    Table 131. Medtronic Corporation Information
    Table 132. Medtronic Description and Major Businesses
    Table 133. Medtronic Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Medtronic Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Medtronic Recent Developments
    Table 136. Allergan Corporation Information
    Table 137. Allergan Description and Major Businesses
    Table 138. Allergan Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Allergan Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Allergan Recent Developments
    Table 141. Boston Scientific Corporation Information
    Table 142. Boston Scientific Description and Major Businesses
    Table 143. Boston Scientific Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Boston Scientific Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Boston Scientific Recent Developments
    Table 146. Novartis Corporation Information
    Table 147. Novartis Description and Major Businesses
    Table 148. Novartis Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Novartis Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Novartis Recent Developments
    Table 151. BD Corporation Information
    Table 152. BD Description and Major Businesses
    Table 153. BD Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. BD Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. BD Recent Developments
    Table 156. Teleflex Incorporated Corporation Information
    Table 157. Teleflex Incorporated Description and Major Businesses
    Table 158. Teleflex Incorporated Drug–Device Combination Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Teleflex Incorporated Drug–Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Teleflex Incorporated Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Drug–Device Combination Products Distributors List
    Table 164. Drug–Device Combination Products Customers List
    Table 165. Drug–Device Combination Products Market Trends
    Table 166. Drug–Device Combination Products Market Drivers
    Table 167. Drug–Device Combination Products Market Challenges
    Table 168. Drug–Device Combination Products Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug–Device Combination Products Product Picture
    Figure 3. Global Drug–Device Combination Products Market Share by Type in 2021 & 2028
    Figure 3. Infusion Pumps Product Picture
    Figure 4. Orthopedic Combination Products Product Picture
    Figure 5. Photodynamic Therapy Devices Product Picture
    Figure 6. Transdermal Patches Product Picture
    Figure 7. Drug Eluting Stents Product Picture
    Figure 8. Wound Care Products Product Picture
    Figure 9. Inhalers Product Picture
    Figure 10. Other Product Picture
    Figure 11. Global Drug–Device Combination Products Market Share by Application in 2021 & 2028
    Figure 12. Hospital
    Figure 13. Clinic
    Figure 14. Other
    Figure 15. Drug–Device Combination Products Report Years Considered
    Figure 16. Global Drug–Device Combination Products Sales 2017-2028 (K Units)
    Figure 17. Global Drug–Device Combination Products Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Drug–Device Combination Products Revenue 2017-2028 (US$ Million)
    Figure 19. Global Drug–Device Combination Products Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Drug–Device Combination Products Sales Market Share by Region (2017-2022)
    Figure 21. Global Drug–Device Combination Products Sales Market Share by Region (2023-2028)
    Figure 22. North America Drug–Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 23. North America Drug–Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Drug–Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 25. Europe Drug–Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Drug–Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 27. Asia-Pacific Drug–Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Drug–Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 29. Latin America Drug–Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Drug–Device Combination Products Sales YoY (2017-2028) & (K Units)
    Figure 31. Middle East & Africa Drug–Device Combination Products Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Drug–Device Combination Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Drug–Device Combination Products in the World: Market Share by Drug–Device Combination Products Revenue in 2021
    Figure 34. Global Drug–Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Drug–Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 36. Global Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 37. Global Drug–Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 38. Global Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 39. North America Drug–Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 40. North America Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 41. North America Drug–Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 42. North America Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 43. North America Drug–Device Combination Products Sales Share by Country (2017-2028)
    Figure 44. North America Drug–Device Combination Products Revenue Share by Country (2017-2028)
    Figure 45. the United States Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Drug–Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 48. Europe Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Drug–Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 50. Europe Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Drug–Device Combination Products Sales Share by Country (2017-2028)
    Figure 52. Europe Drug–Device Combination Products Revenue Share by Country (2017-2028)
    Figure 53. Germany Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 54. France Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 55. UK Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Drug–Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Drug–Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Drug–Device Combination Products Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Drug–Device Combination Products Revenue Share by Region (2017-2028)
    Figure 64. China Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 67. India Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 69. China Taiwan Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Drug–Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Drug–Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Drug–Device Combination Products Sales Share by Country (2017-2028)
    Figure 78. Latin America Drug–Device Combination Products Revenue Share by Country (2017-2028)
    Figure 79. Mexico Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Drug–Device Combination Products Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Drug–Device Combination Products Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Drug–Device Combination Products Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Drug–Device Combination Products Revenue Share by Country (2017-2028)
    Figure 88. Turkey Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 90. UAE Drug–Device Combination Products Revenue (2017-2028) & (US$ Million)
    Figure 91. Drug–Device Combination Products Value Chain
    Figure 92. Drug–Device Combination Products Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Speak To Analyst

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

Related Reports

Global Laparotomy Pads Market Insights, Forecast to 2028
  • Report ID:188138
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: May-22
  • No. of Pages: 112
  • 3480

(COVID Version) Global Medical Loupes Market Status (2016-2020) and Forecast (2021E-2026F...
  • Report ID:137372
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: May-22
  • No. of Pages: 112
  • 3000

Global Cartilage Regeneration Market 2021 by Company, Regions, Type and Application, Fore...
  • Report ID:46081
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: May-22
  • No. of Pages: 112
  • 3480

Global Pedicle Screws Market Insights and Forecast to 2028
  • Report ID:219170
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: May-22
  • No. of Pages: 112
  • 3480

Global Electroosmotic Pump Market Insights, Forecast to 2028
  • Report ID:245503
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: May-22
  • No. of Pages: 112
  • 3480

clock

+1  347 708 0418

clocksales@acorinsights.com

trusted-site ssl paypal

COPYRIGHT © 2021 Acor Insights | All Rights Reserved.